Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00692653 · ClinicalTrials.gov registry record · NA

Personal Patient Profile Prostate (P4) Randomized, Multisite Trial

A NA study of Prostate Cancer, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
498
Enrollment target
6
Study locations

NCT00692653 is a NA study of Prostate Cancer that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 498 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00692653, a NA study of Prostate Cancer, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
498 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about treatment for their early stage prostate cancer. The P4 program consists of a series of questions and information for the participant. Before seeing the cancer specialist, participants will answer several questionnaires on a computer. This will take about 20-30 minutes. Participants may choose to do this on a computer at home or on a touch-screen computer in the clinic. Half the participants will then be shown several highly rated informational websites about prostate cancer treatments. The other half, based on the individual participant's answers, will receive the P4 program's customized written and on-screen information. Reading the information and watching videos will take about 20 minutes. About one month later, and again 6 months, participants will complete follow-up questionnaires electronically or by mail. These questionnaires will help us understand how each participant's decision for treatment of their prostate cancer went. Answering these questionnaires should take about 20 minutes each time.

Conditions Studied

Prostate Cancer

Interventions

  • BEHAVIORAL P4

Study Locations (6)

Washington

  • Seattle Prostate Institute - Seattle
  • Veterans Administration Puget Sound Health Care System - Seattle
  • University of Washington Medical Center - Seattle

Georgia

  • VA Medical Center / Medical College of Georgia - Augusta

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia

Texas

  • University of Texas Health Sciences Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 498 participants
Start Date 2007-02
Est. Completion 2009-12
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00692653

The ClinicalTrials.gov registry entry for NCT00692653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 498 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which P4 is the first listed.

NCT00692653 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Washington, Georgia, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00692653 about?

NCT00692653 is a clinical study titled "Personal Patient Profile Prostate (P4) Randomized, Multisite Trial". The purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about treatment for their early stage prostate cancer. The P4 program consists of a series of questions and information for the partic...

What is the current status of trial NCT00692653?

This trial is currently completed. It is a NA study. The enrollment target is 498 participants. The study started on 2007-02. Estimated completion is 2009-12.

What conditions does trial NCT00692653 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00692653?

The interventions under investigation include: P4 (BEHAVIORAL).

Who is sponsoring clinical trial NCT00692653?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00692653 being conducted?

This trial has 6 study locations across Georgia, Pennsylvania, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.